X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Edelweiss Financial with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EDELWEISS FINANCIAL vs INDOCO REMEDIES - Comparison Results

EDELWEISS FINANCIAL    Change

Edelweiss is among the larger institutional brokerage firms in India, with a strong domestic investment-banking business. It has a good market share in the institutional broking, and strong presence in derivatives. While its strengths remain in priva... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    EDELWEISS FINANCIAL INDOCO REMEDIES EDELWEISS FINANCIAL/
INDOCO REMEDIES
 
P/E (TTM) x 24.4 44.4 55.0% View Chart
P/BV x 3.5 2.8 125.8% View Chart
Dividend Yield % 0.5 0.8 56.3%  

Financials

 EDELWEISS FINANCIAL   INDOCO REMEDIES
EQUITY SHARE DATA
    EDELWEISS FINANCIAL
Mar-18
INDOCO REMEDIES
Mar-17
EDELWEISS FINANCIAL/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs309360 85.8%   
Low Rs157249 62.9%   
Sales per share (Unadj.) Rs93.7119.0 78.8%  
Earnings per share (Unadj.) Rs9.78.4 116.3%  
Cash flow per share (Unadj.) Rs10.915.2 71.8%  
Dividends per share (Unadj.) Rs1.351.60 84.4%  
Dividend yield (eoy) %0.60.5 110.3%  
Book value per share (Unadj.) Rs72.970.7 103.1%  
Shares outstanding (eoy) m915.5092.15 993.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.52.6 97.1%   
Avg P/E ratio x24.036.4 65.8%  
P/CF ratio (eoy) x21.320.0 106.5%  
Price / Book Value ratio x3.24.3 74.2%  
Dividend payout %13.919.1 72.6%   
Avg Mkt Cap Rs m213,40328,083 759.9%   
No. of employees `00010.16.0 166.5%   
Total wages/salary Rs m13,5492,167 625.3%   
Avg. sales/employee Rs Th8,536.61,817.0 469.8%   
Avg. wages/employee Rs Th1,347.9359.0 375.5%   
Avg. net profit/employee Rs Th885.5127.7 693.5%   
INCOME DATA
Net Sales Rs m85,81010,968 782.4%  
Other income Rs m37640 947.6%   
Total revenues Rs m86,18611,007 783.0%   
Gross profit Rs m50,2181,565 3,209.7%  
Depreciation Rs m1,117633 176.5%   
Interest Rs m35,29562 56,836.1%   
Profit before tax Rs m14,182909 1,559.5%   
Minority Interest Rs m2780-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,599139 4,036.4%   
Profit after tax Rs m8,901771 1,155.0%  
Gross profit margin %58.514.3 410.2%  
Effective tax rate %39.515.3 258.8%   
Net profit margin %10.47.0 147.6%  
BALANCE SHEET DATA
Current assets Rs m385,9995,725 6,742.6%   
Current liabilities Rs m260,4895,454 4,776.0%   
Net working cap to sales %146.32.5 5,926.1%  
Current ratio x1.51.0 141.2%  
Inventory Days Days68962 1,107.0%  
Debtors Days Days11272 155.6%  
Net fixed assets Rs m7,5385,307 142.0%   
Share capital Rs m916184 496.7%   
"Free" reserves Rs m65,7916,331 1,039.2%   
Net worth Rs m66,7066,516 1,023.8%   
Long term debt Rs m273,0611,323 20,637.9%   
Total assets Rs m635,13511,970 5,306.2%  
Interest coverage x1.415.6 9.0%   
Debt to equity ratio x4.10.2 2,015.8%  
Sales to assets ratio x0.10.9 14.7%   
Return on assets %7.07.0 100.0%  
Return on equity %13.311.8 112.8%  
Return on capital %14.712.4 118.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1904,507 4.2%   
Fx outflow Rs m571,141 5.0%   
Net fx Rs m1333,366 4.0%   
CASH FLOW
From Operations Rs m-111,375886 -12,564.9%  
From Investments Rs m-23,283-1,706 1,365.2%  
From Financial Activity Rs m148,3461,316 11,275.1%  
Net Cashflow Rs m13,508497 2,720.2%  

Share Holding

Indian Promoters % 37.3 59.2 63.0%  
Foreign collaborators % 0.1 0.0 -  
Indian inst/Mut Fund % 0.0 12.5 -  
FIIs % 21.1 6.0 351.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.5 22.4 185.3%  
Shareholders   134,647 12,805 1,051.5%  
Pledged promoter(s) holding % 52.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare EDELWEISS FINANCIAL With:   JSW HOLDINGS  INDIABULLS FIN. SER.  COMPACT DISC  COX & KINGS  COMMEX TECHNOLOGY  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

TORRENT PHARMA at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

Aug 17, 2018 | Updated on Aug 17, 2018

TORRENT PHARMA share price has hit a 52-week high. It is presently trading at Rs 1,770. BSE 500 Index is up by 1.0% at 15,508. Within the BSE 500, TORRENT PHARMA (up 4.2%) and EDELWEISS FINANCIAL (up 8.5%) are among the top gainers, while top losers are TECHNO ELECTRIC and ZENSAR TECHNOLOGIES.

EDELWEISS FINANCIAL Announces Quarterly Results (1QFY19); Net Profit Up 31.2% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, EDELWEISS FINANCIAL has posted a net profit of Rs 3 bn (up 31.2% YoY). Sales on the other hand came in at Rs 24 bn (up 29.0% YoY). Read on for a complete analysis of EDELWEISS FINANCIAL's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

EDELWEISS FINANCIAL SHARE PRICE


Aug 17, 2018 (Close)

TRACK EDELWEISS FINANCIAL

  • Track your investment in EDELWEISS FINANCIAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON EDELWEISS FINANCIAL

EDELWEISS FINANCIAL - INDOCO REMEDIES COMPARISON

COMPARE EDELWEISS FINANCIAL WITH

MARKET STATS